Market cap
$11,688 Mln
Revenue (TTM)
$19,359 Mln
P/E Ratio
11.3
P/B Ratio
0.8
Div. Yield
3.8 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$827 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
29.24
-
EV/EBITDA
5.7
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$1.6
-
Face value
--
-
Shares outstanding
537,129,260
10 Years Aggregate
CFO
€23,696.74 Mln
EBITDA
€26,482.27 Mln
Net Profit
€10,750.53 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| -9.9 | -9.5 | -12.2 | -23.3 | -3.0 | -11.9 | -6.4 |
|
BSE Sensex*
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| 5.2 | 8.6 | 27.5 | -49.7 | -21.9 | 12.8 | 13.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Fresenius Medical Care AG - ADR
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a... network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352 Read more
-
CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
Ms. Helen Giza
-
Chair of Management Board & CEO
Ms. Helen Giza
-
Headquarters
Bad Homburg
-
Website
FAQs for Fresenius Medical Care AG - ADR
What is the current share price of Fresenius Medical Care AG - ADR Today?
The share price of Fresenius Medical Care AG - ADR is $21.47 (NYSE) as of 14-May-2026 16:00 EDT. Fresenius Medical Care AG - ADR has given a return of -2.99% in the last 3 years.
What is the current PB & PE ratio of Fresenius Medical Care AG - ADR?
The P/E ratio of Fresenius Medical Care AG - ADR is 11.27 times as on 12-May-2026, a 61 discount to its peers’ median range of 29.24 times.
The P/B ratio of Fresenius Medical Care AG - ADR is 0.76 times as on 12-May-2026, a 59 discount to its peers’ median range of 1.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.93
|
0.95
|
|
2024
|
49.40
|
1.82
|
|
2023
|
36.73
|
1.35
|
|
2022
|
28.45
|
1.37
|
|
2021
|
29.71
|
2.27
|
What is the 52 Week High and Low of Fresenius Medical Care AG - ADR?
The 52-week high and low of Fresenius Medical Care AG - ADR are Rs 30.46 and Rs 20.02 as of 15-May-2026.
What is the market cap of Fresenius Medical Care AG - ADR?
Fresenius Medical Care AG - ADR has a market capitalisation of $ 11,688 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Fresenius Medical Care AG - ADR?
Before investing in Fresenius Medical Care AG - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.